Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 3-month, Multi-center, Double-blind, Randomized Study to Evaluate the Efficacy of Levodopa/Carbidopa/Entacapone vs Levodopa/Carbidopa in Parkinson's Disease Patients With Impairment of Activities of Daily Living and Early Wearing-off With Levodopa

NCT00391898 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00391898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00391898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 3-month, Multi-center, Double-blind, Randomized Study to Evaluate the Efficacy of Levodopa/Carbidopa/Entacapone vs Levodopa/Carbidopa in Parkinson's Disease Patients With Impairment of Activities of Daily Living and Early Wearing-off With Levodopa
Lead sponsor
Novartis
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2006
Completion date
June 30, 2008
Enrollment
95 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease